qPCR 儀器市場機會、成長動力、產業趨勢分析與預測 2024 - 2032 年

2023 年，全球 qPCR 儀器市場價值 16 億美元，預計 2024 年至 2032 年複合年成長率為 8.4%。全球各種疾病發病率的不斷上升極大地增加了對 qPCR 等即時定量工具的需求。這些工具對於診斷和監測傳染病、癌症和遺傳性疾病至關重要，因為它們能夠提供快速、準確的結果。都市化、人口老化和生活方式改變等因素導致非傳染性疾病的增加，進一步推動了對 qPCR 技術的需求，特別是在感染率和慢性病高發生的地區。

對個人化醫療的日益關注也是推動 qPCR 儀器市場的關鍵因素。個人化醫療依賴精確的分子診斷，而 qPCR 可以實現詳細的基因分析和即時監測。這種能力對於開發個人化治療、識別基因突變和客製化治療以滿足患者的特定需求至關重要。隨著個人化治療需求的持續成長，qPCR 在藥物開發和標靶治療等領域的作用變得越來越突出，支持市場擴張。

就產品類型而言，qPCR 系統領域在 2023 年引領市場，創造 6.442 億美元的收入。這些系統是即時 PCR 檢測的支柱，為診斷、研究和藥物開發中的定量分析提供關鍵平台。鑑於實驗室、醫院和診所的購買和安裝需要大量投資，qPCR 系統是市場中資本最密集的部分。然而，這些機器廣泛用於各種應用，使其成為總收入的關鍵貢獻者。

依應用，市場分為基因表現、基因分型、病原體檢測、診斷等。 2023年，基因表現部分佔最大佔有率，達26.6%。基因表現分析在分子生物學中發揮關鍵作用，幫助研究人員了解各種條件下的基因調控和表達，特別是在癌症研究、藥物開發和疾病機制研究。這使得 qPCR 儀器對於此類應用至關重要，從而推動了持續的需求。

從地區來看，北美地區2023 年的銷售額為6.21 億美元，預計到2032 年將以8.1% 的複合年成長率成長。北美地區對先進診斷工具的需求。 qPCR 儀器以其準確性和速度而聞名，有助於快速檢測病原體，使醫療保健提供者能夠有效管理疾病爆發。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 疾病盛行率增加
    • 技術進步
    • 強調個人化醫療
    • 合約研究組織 (CRO) 的發展
  • 產業陷阱與挑戰
    • 設備成本高
• 成長潛力分析
• 監管環境
• 技術景觀
• 未來市場趨勢
• 差距分析
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按產品類型，2021 - 2032 年

• 主要趨勢
• 定量PCR系統
• 試劑及耗材
• 軟體

第 6 章：市場估計與預測：按應用分類，2021 - 2032

• 主要趨勢
• 基因表現
• 基因分型
• 病原體檢測
• 診斷
• 其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

• 主要趨勢
• 診斷實驗室
• 醫院和診所
• 製藥和生物技術公司
• 其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 9 章：公司簡介

• Abbott Laboratories
• Agilent Technologies, Inc.
• Azure Biosystems Inc.
• Bio Molecular Systems
• BIOMERIEUX SA
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Eppendorf
• F. Hoffmann-La Roche Ltd.
• Merck KGaA
• QIAGEN NV
• Quantabio
• Siemens Healthineers AG
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

The Global qPCR Instruments Market was valued at USD 1.6 billion in 2023 and is projected to grow at a CAGR of 8.4% from 2024 to 2032. Key drivers for this growth include the rising prevalence of diseases and an increasing focus on personalized medicine. The growing incidence of various diseases worldwide has significantly boosted the demand for real-time quantification tools like qPCR. These tools are crucial for diagnosing and monitoring infectious diseases, cancer, and genetic disorders due to their ability to provide rapid and accurate results. Factors such as urbanization, aging populations, and lifestyle changes have contributed to the rise in non-communicable diseases, further driving the need for qPCR technology, especially in areas with high rates of infections and chronic conditions.

The rising focus on personalized medicine is also a key factor propelling the qPCR instruments market. Personalized medicine relies on precise molecular diagnostics, and qPCR enables detailed genetic profiling and real-time monitoring. This capability is essential for developing individualized treatments, identifying genetic mutations, and tailoring therapies to meet the specific needs of patients. As the demand for personalized therapies continues to grow, qPCR's role in areas like drug development and targeted treatments is becoming more prominent, supporting market expansion.

In terms of product types, the qPCR systems segment led the market in 2023, generating USD 644.2 million. These systems are the backbone of real-time PCR testing, providing critical platforms for quantitative analysis in diagnostics, research, and drug development. qPCR systems are the most capital-intensive segment of the market, given the substantial investment required for their purchase and installation in labs, hospitals, and clinics. However, these machines are extensively utilized for various applications, making them a key contributor to overall revenue.

Based on application, the market is segmented into gene expression, genotyping, pathogen detection, diagnostics, and others. In 2023, the gene expression segment held the largest share, at 26.6%. Gene expression analysis plays a key role in molecular biology, helping researchers understand gene regulation and expression under various conditions, particularly in cancer research, drug development, and disease mechanism studies. This makes qPCR instruments vital for such applications, driving consistent demand.

Regionally, North America accounted for USD 621 million in 2023 and is expected to grow at a CAGR of 8.1% through 2032. The rising incidence of infectious diseases like HIV, influenza, and COVID-19 has significantly increased the demand for advanced diagnostic tools in the region. qPCR instruments, known for their accuracy and speed, are instrumental in detecting pathogens quickly, enabling healthcare providers to manage disease outbreaks effectively.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of diseases
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Emphasis on personalized medicine
    • 3.2.1.4 Growth of contract research organizations (CROs)
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of devices
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 qPCR systems
• 5.3 Reagents and consumables
• 5.4 Software

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Gene expression
• 6.3 Genotyping
• 6.4 Pathogen detection
• 6.5 Diagnostics
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Diagnostics laboratories
• 7.3 Hospitals & clinics
• 7.4 Pharma & biotech companies
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Agilent Technologies, Inc.
• 9.3 Azure Biosystems Inc.
• 9.4 Bio Molecular Systems
• 9.5 BIOMERIEUX SA
• 9.6 Bio-Rad Laboratories, Inc.
• 9.7 Danaher Corporation
• 9.8 Eppendorf
• 9.9 F. Hoffmann-La Roche Ltd.
• 9.10 Merck KGaA
• 9.11 QIAGEN N.V.
• 9.12 Quantabio
• 9.13 Siemens Healthineers AG
• 9.14 Takara Bio Inc.
• 9.15 Thermo Fisher Scientific Inc.